8-K: NN, Inc. Reports Mixed Q1 2025 Results, Reaffirms Adjusted EBITDA Outlook but Lowers Sales Guidance

NN, Inc. announced its Q1 2025 results, reaffirming its full-year adjusted EBITDA outlook and five-year targets, while initiating free cash flow guidance and adjusting net sales expectations due to economic uncertainties.

Summary

• NN, Inc. reported net sales of $105.7 million for Q1 2025, a 12.8% decrease compared to the prior year.
• Pro forma net sales, adjusted for divestitures and currency translation, decreased by 1.3%.
• The company's GAAP earnings per share was $(0.23), and adjusted earnings per share was $(0.03), an increase compared to the prior year.
• Pro forma adjusted EBITDA was $10.6 million, flat compared to the prior year, with an adjusted EBITDA margin of 10%.
• New business wins totaled $16.4 million, focused on industrial, electrical, medical, and automotive products.
• The new business pipeline remains robust at over $740 million.
• NN is initiating full-year 2025 free cash flow guidance of $14 to $16 million.
• The company is reaffirming its full-year adjusted EBITDA guidance of $53 to $63 million.
• Net sales guidance has been adjusted to $430 to $460 million due to economic uncertainties.
• NN has won 120 new programs worth $55 million in peak annual sales launching in 2025.
• The company expects $15 million in cost reductions in 2025.
• The company completed a term loan refinancing post quarter-end.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While sales are down, the company is reaffirming EBITDA guidance and focusing on cost reductions and new business wins. The initiation of free cash flow guidance is also a positive sign.

Positives

• Adjusted earnings per share improved compared to the prior year.
• Adjusted EBITDA margin increased to 10% from 9.3% in the prior year.
• New business wins totaled $16.4 million, concentrated in key focus areas.
• The company's new business pipeline remains robust at over $740 million.
• NN is initiating full-year 2025 free cash flow guidance of $14 to $16 million.
• The company completed a term loan refinancing post quarter-end.
• Strong China domestic sales growth continues, up by 12.5% versus the prior year first quarter.
• NN's medical pipeline is currently at peak levels of $40+ million since re-entering the medical market in October 2023.

Negatives

• Net sales decreased by 12.8% compared to the prior year.
• Free cash flow was a use of cash of $7.1 million compared to a generation of cash of $0.3 million for the same period in 2024.
• Loss from operations for the first quarter of 2025 was $4.8 million, flat compared to prior year.
• Net sales guidance has been adjusted to $430 to $460 million due to economic uncertainties.

Risks

• Heightened macroeconomic uncertainty could impact the company's performance.
• The threat of U.S. tariffs, though currently immaterial, could pose a future risk.
• Global economic uncertainty is expected to push adjusted EBITDA guidance towards the lower half of the provided range.
• The company faces risks related to general economic conditions, competitive influences, and material changes in raw material costs.
• The company is dependent on certain major customers, some of whom are not parties to long-term agreements.

Future Outlook

NN, Inc. expects to continue driving organic growth, reduce its cost profile, and increase its cash flow, with 2025 serving as a pivotal year in its progression.

Management Comments

• Harold Bevis, President and Chief Executive Officer of NN, Inc., stated that the company marked another quarter of solid steps forward across key areas of its transformation.
• Mr. Bevis noted that the company's commercial growth agenda captured $16.4 million of new business wins in the quarter.
• Chris Bohnert, Senior Vice President and Chief Financial Officer, commented that the direct impacts of tariff and trade negotiations are immaterial to the company's results and, as a result, they are maintaining their full-year 2025 guidance range for adjusted EBITDA.
• Chris Bohnert expects prevailing market conditions to push adjusted EBITDA guidance towards the lower half of the provided range.

Industry Context

NN, Inc. operates in the global diversified industrial sector, facing challenges such as economic uncertainty and potential impacts from tariffs. The company is focusing on growth in specific markets like medical and electrical products to diversify its revenue streams.

Comparison to Industry Standards

• It is difficult to compare NN, Inc. directly to industry standards without more specific information on its competitive landscape.
• However, companies like Altra Industrial Motion, RBC Bearings, and Timken are in similar industries.
• NN, Inc.'s focus on cost reduction and margin improvement aligns with industry trends aimed at enhancing profitability.
• The company's efforts to diversify into non-automotive sectors mirror strategies employed by other industrial manufacturers to mitigate cyclical risks.

Stakeholder Impact

• Shareholders can expect continued focus on profitability and cash flow generation.
• Employees may experience further staff reductions as part of the cost reduction initiatives.
• Customers can anticipate continued investment in new products and services.
• Suppliers may face pressure to reduce costs as part of the company's cost reduction efforts.
• Creditors benefit from the company's focus on improving its balance sheet and generating free cash flow.

Next Steps

• NN will discuss its results during its quarterly investor conference call on May 8, 2025.
• The company will continue to execute against its cost-out and plant level productivity enhancement initiatives.
• NN will continue to leverage $340 million of machinery and equipment to minimize cash capex spend.

Key Dates

Keywords

financial results, EBITDA, net sales, free cash flow, industrial components, manufacturing, NN, Inc.